- Home
- Internal Medicine
- Advancing Treatment of MDR Gram-Negative Infections with Ceftolozane/Tazobactam
1mo3 min read
Medical Article
Introduction: Hospital-acquired infections, particularly hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP), are major contributors to morbidity and mortality in critically ill patients (1). The growing prevalence of multidrug-resistant (MDR) Gram-negative pathogens, especially Pseudomonas aeruginosa,

Advancing Treatment of MDR Gram-Negative Infections with Ceftolozane/Tazobactam
Similar Content

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

Case of Pulmonary Embolism with Syncope
544 Reached4 Likes

Vildagliptin in Reducing Risk of Post-partum Diabetes
2386 Reached7 Comments4 Likes
